History
2026
- 04
- IND Submission (US FDA)
- 01
- EUROPE Patent Approved for AL04 (EPO)
- 01
- BIOTECH SHOWCASE in San Francisco
- 01
- BIO PARTNERING @JPM WEEK in San Francisco
2025
- 08
- JAPAN Patent Approved for AL04 (JPO)
- 06
- BIO International Convention in Boston
- 03
- FDA CMC Meeting
2024
- 11
- Publication in Neuroscience Reports
- 10
- US Patent Approved for AL04 (USPTO)
- 07
- Added Poster Presentation at the AAIC in Philadelphia
(Alzheimer's Association International Conference)
- 06
- Presentation of BIO International Convention in San Diego
- 01
- Presentation of JPM Biotech Showcase
in San Francisco
2022
- 10
- Publication in Neuroscience Letters
- 08
- Pre-IND Submission (US FDA)
2021
- 12
- Signing of CRO Contract for Preclinical Studies
and Progression of Preclinical Trials
2020
- 01
- Holding an IR Presentation
2019
- 11
- Industry partner in a national project for
developing membrane modules
and culture systems for cell cultivation.
- 08
- Patent Application for 'Method for
Treating Central nervous system disease (AL04)'
- 05
- Venture Company Certification
2018
- 06
- Certification of In-House Research Institute
2017
- 09
- Acquire a Patent 'Method for Treating Shingles with
N-Methanocarbathymidine (N-MCT)'
2016
- 12
- Establishment of L&J BIO, Co., Ltd. (KR)
2012
- 10
- Establishment of L&J BIO
